a public good project by the
Synthesis
Company
of California

© 2026

Kamel El Harkani | doi.page

0 works0 citations0 h-index

Google Scholar OpenAlex

Kamel El Harkani

Merck Serono (Switzerland)(CH)

Research Areas

Neuropeptides and Animal Physiology, Hormonal and reproductive studies, Receptor Mechanisms and Signaling

Most-Cited Works

→ Discovery of a Novel Series of CRTH2 (DP2) Receptor Antagonists Devoid of Carboxylic Acids(2011)16 cited